NSE · CORONA
CORONA Remedies Limited (CORONA) Share Price
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#481
of 5,047 stocks
▼ 371W▲ 491M
Peak #444 · 08 Nov 2026
CORONA Remedies Limited is a midcap company in the Healthcare space and carries a steep earnings multiple that prices in strong future growth, generates a high return on equity, and remains firmly promoter-controlled, with promoters holding 69%.
Market Cap
13,998.30 Cr
P/E Ratio
75.61
P/B Ratio
18.74
ROE
24.79%
ROCE
31.54%
Dividend Yield
0.44%
52W High
—
52W Low
—
Quarterly financials
| Metric | Q2 2026-27 | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 |
|---|---|---|---|---|
| Revenue | 441.17 Cr | 422.43 Cr | 353.09 Cr | 342.42 Cr |
| Net Profit | 60.31 Cr | 60.11 Cr | 45.33 Cr | 41.27 Cr |
| EPS | 9.86 | 9.83 | 7.41 | 6.75 |
| Operating Profit | 83.37 Cr | 83.04 Cr | 55.84 Cr | 75.95 Cr |
Shareholding pattern
Promoter
69.00%
Public
31.00%
PUBLIC BREAKDOWN
FII
3.63%
DII
12.90%
MF (within DII)
12.50%
Individuals
0.90%
Mutual fund holdings
₹1,997.89
Cr total
37
Schemes
9
Fund Houses
₹1,997.89 Cr
Total Exposure
Invesco Mutual Fund₹710.96 Cr (35.6%)
HDFC Mutual Fund₹538.84 Cr (27.0%)
SBI Mutual Fund₹468.69 Cr (23.5%)
Aditya Birla Sun Life Mutual Fund₹126.11 Cr (6.3%)
WhiteOak Capital Mutual Fund₹121.30 Cr (6.1%)
Others₹31.99 Cr (1.6%)
| Scheme | Fund House | Value (Cr) | % |
|---|
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 19 Jun 2026 | Dividend | Dividend - Rs 10 Per Share |
Other Healthcare stocks
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.